What This Immunome Sale Signals Ahead of FDA Milestone
When a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
Explore year-end ETF Tax-Loss Harvesting ideas to harvest losses before year-end, diversify replacements, and sharpen tax efficiency.
25,086 articlesWhen a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
A highly focused 3x Korea fund rides a memory-chip demand wave to striking gains, but risk factors and regulatory scr...
As AI enthusiasm shakes up the tech market, Microsoft stands out as a potentially steadier megacap. This article brea...
A respected analyst has earmarked Dutch Bros as the best restaurant stock pick, citing traffic gains, digital momentu...
Carlisle Companies stands out as a strong contender in the building products arena thanks to its diversified mix, dis...
Arm is venturing into silicon design after decades as a licensing powerhouse. This bold shift could impact AI data ce...
New data shows high-end metro areas are turning over listings faster than mid-priced markets, upending expectations a...
A 40-year-old, freshly divorced, earns $85,000 with no savings. Financial planners say a disciplined plan could reach...
A single quarterly filing can rewrite a fund’s star players. Tepper’s Appaloosa appears to have shifted away from NVI...
AMD stock soared in May as AI-driven demand, data center expansion, and a refreshed product lineup converged to lift ...
Nebius Group has rocketed more than 240% this year. Before you jump in, learn how to weigh momentum against fundament...
A major investor stepped into Crocs with a sizable new stake, valuing the position at about $53.7 million even as CRO...